OTC : BOEUF
-$0.92 (-4.28%)
OTC
Torbjorn Skold
Medical - Devices
Healthcare
BOEUF
160
SE
USD
0.02
5.13
4.23
2.62
0.00
$1.17B
10.89
14.17
53.81
3.73
$2.12
$142.15M
15.23%
20.94%
23.82%
19.10%
71.89
1.63
1.63
3/5
0 Analysts
%
47.91
5/9
$733.49M
$1.12B
$177.32M
$306.83M
$12.62B
9.81
39.52
5.44
23.82%
23.14%
1.63%
2.01%
$32.46
558 days
| Name | Title |
|---|---|
| Michael Wrang Mortensen | Executive Vice President of Global R&D and Operations |
| Anna Stegmark | Executive Vice President of Quality Management & Regulatory Affairs |
| Michael Diefenbeck | Executive Vice President of Medical & Clinical Affairs and Chief Medical Officer |
| Michael Roth | GM & Executive VP of Commercial Operations of US |
| Torbjorn Skold | Chief Executive Officer |
| Annelie Aava Vikner | Executive Vice President of Global Marketing |
| Helena L. Brandt | Executive Vice President of Human Resources |
| Håkan Johansson | Chief Financial Officer |
| Fergus MacLeod | GM & Executive Vice President of Commercial Operations of EUROW |
No votes yet today — be the first to share your view!
About Bonesupport Holding AB (publ) (OTC:BOEUF) Stock
Bonesupport Holding AB (publ) is an orthobiologics firm that develops and commercializes injectable bioceramic solutions designed to treat bone voids. These products are distributed across Europe, North America, and globally. The company's portfolio includes CERAMENT Bone Void Filler, a synthetic material that can be injected, molded, and drilled, containing hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol for visibility. They also offer CERAMENT G, a ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Beyond its existing offerings, Bonesupport engages in preclinical development of products aimed at promoting bone regrowth. This research focuses on areas such as trauma, revision joint replacement su ... rgeries, chronic osteomyelitis, oncology, and bone and foot infections associated with diabetes. Established in 1999, the company is headquartered in Lund, Sweden.
Bonesupport Holding AB (publ) (BOEUF) Q2 2026 Earnings Call Transcript
2026-07-16 13:46:17
Bonesupport Holding AB (publ) (BOEUF) Q2 2026 Earnings Call Transcript
Bonesupport Holding AB (publ) (BOEUF) Q1 2026 Earnings Call Transcript
2026-04-22 08:00:35
Bonesupport Holding AB (publ) (BOEUF) Q1 2026 Earnings Call Transcript
Frequently Asked Questions
What is the current Bonesupport Holding AB (publ) (BOEUF) stock price?
Bonesupport Holding AB (publ)(OTC:BOEUF) stock price is $20.485 in the last trading session. During the trading session, BOEUF stock reached the peak price of $35 while $18.57 was the lowest point it dropped to. The percentage change in BOEUF stock occurred in the recent session was --4.28% while the dollar amount for the price change in BOEUF stock was -$0.92.
BOEUF's industry and sector of operation?
The OTC listed BOEUF is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of BOEUF?
Michael Wrang Mortensen
| Executive Vice President of Global R&D and Operations
Anna Stegmark
| Executive Vice President of Quality Management & Regulatory Affairs
Michael Diefenbeck
| Executive Vice President of Medical & Clinical Affairs and Chief Medical Officer
Michael Roth
| GM & Executive VP of Commercial Operations of US
Torbjorn Skold
| Chief Executive Officer
How many employees does BOEUF have?
Number of BOEUF employees currently stands at 160. BOEUF operates from Scheelevägen 19, Lund, SN 223 70, SE.
Link for BOEUF official website?
Official Website of BOEUF is: https://www.bonesupport.com
How do I contact BOEUF?
BOEUF could be contacted at phone #46 4 62 86 53 70 and can also be accessed through its website. BOEUF operates from Scheelevägen 19, Lund, SN 223 70, SE.
How many shares of BOEUF are traded daily?
The average number of BOEUF shares traded daily for last 3 months was 93.
What is the market cap of BOEUF currently?
The market value of BOEUF currently stands at $1.34B with its latest stock price at $20.485